Robert Somerville
Cellular Therapeutics (United Kingdom)(GB)National Institutes of Health Clinical Center(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer
Most-Cited Works
- → Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer(2014)1,692 cited
- → Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor(2014)1,600 cited
- → Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer(2018)763 cited
- → Immunogenicity of somatic mutations in human gastrointestinal cancers(2015)723 cited
- → Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease(2016)603 cited
- → Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels